# Useful Downloads - De-identified, Anonymized FHIR Profiles Library v1.0.0-ballot

* [**Table of Contents**](toc.md)
* **Useful Downloads**

## Useful Downloads

| |
| :--- |
| *Page standards status:*[Trial-use](http://hl7.org/fhir/R4/versions.html#std-process) |

 Download the entire implementation guide [here](full-ig.zip) 

* Artifact Definitions: Examples
  * [XML](definitions.xml.zip): [XML](examples.xml.zip)
  * [JSON](definitions.json.zip): [JSON](examples.json.zip)
  * [Turtle](definitions.ttl.zip): [Turtle](examples.ttl.zip)

### Cross Version Analysis

This is an R4 IG. None of the features it uses are changed in R4B, so it can be used as is with R4B systems. Packages for both [R4 (hl7.fhir.us.dapl.r4)](package.r4.tgz) and [R4B (hl7.fhir.us.dapl.r4b)](package.r4b.tgz) are available.
#### Dependency Table






#### Globals Table
*There are no Global profiles defined*
#### IP Statements
This publication includes IP covered under the following statements.

* ISO maintains the copyright on the country codes, and controls its use carefully. For further details see the ISO 3166 web page: [https://www.iso.org/iso-3166-country-codes.html](https://www.iso.org/iso-3166-country-codes.html)

* [ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code](http://terminology.hl7.org/5.5.0/CodeSystem-ISO3166Part1.html): [DAPL](index.md), [DAPLAgeExtension](StructureDefinition-dapl-age-extension.md)... Show 26 more, [DAPLAnonymizedDataset](StructureDefinition-dapl-anonymized-dataset.md), [DAPLClinicalResultObservation](StructureDefinition-dapl-clinical-result-observation.md), [DAPLCoverage](StructureDefinition-dapl-coverage.md), [DAPLDeIdentifiedInstantExtension](StructureDefinition-dapl-deidentified-instant-extension.md), [DAPLDeIdentifiedPatient](StructureDefinition-dapl-deidentified-patient.md), [DAPLDeidentifiedAdverseEvent](StructureDefinition-dapl-deidentified-adverseevent.md), [DAPLDeidentifiedAllergyIntolerance](StructureDefinition-dapl-deidentified-allergyintolerance.md), [DAPLDeidentifiedLocation](StructureDefinition-dapl-deidentified-location.md), [DAPLDeidentifiedOrganization](StructureDefinition-dapl-deidentified-organization.md), [DAPLDeidentifiedRaceExtension](StructureDefinition-dapl-race-extension.md), [DAPLDeidentifiedRelatedPerson](StructureDefinition-dapl-deidentified-relatedperson.md), [DAPLDiagnosis](StructureDefinition-dapl-diagnosis.md), [DAPLEncounter](StructureDefinition-dapl-deidentified-encounter.md), [DAPLEthnicityExtension](StructureDefinition-dapl-ethnicity-extension.md), [DAPLEventRecordedDateTimeExtension](StructureDefinition-dapl-event-recorded-datetime-extension.md), [DAPLImmunization](StructureDefinition-dapl-immunization.md), [DAPLIncomeObservation](StructureDefinition-dapl-income-observation.md), [DAPLLabObservation](StructureDefinition-dapl-lab-observation.md), [DAPLMeasureStratifierComponentValueExtension](StructureDefinition-dapl-measure-stratifier-component-value-extension.md), [DAPLMedicationRequest](StructureDefinition-dapl-medicationrequest.md), [DAPLMedicationStatement](StructureDefinition-dapl-medicationstatement.md), [DAPLProcedure](StructureDefinition-dapl-procedure.md), [DAPLRecordedDateExtension](StructureDefinition-dapl-recordedDate-extension.md), [DAPLServiceRequest](StructureDefinition-dapl-servicerequest.md), [DAPLSexCodes](ValueSet-dapl-sex-codes.md) and [DAPLSexExtension](StructureDefinition-dapl-sex-extension.md)


* Licensing information can be found [here](https://www.nubc.org/license) These codes are listed within the UB-04 Data Specifications Manual. The Official UB-04 Data Specifications Manual, copyrighted by the American Hospital Association, is the only official source of UB-04 billing information adopted by the National Uniform Billing Committee. No other publication—governmental or private/commercial—can be considered authoritative. The AHA wants to make you aware that the use of codes, descriptions, or any other content contained in the manual to be used in a software application, publication, or any other derivative work must be properly licensed by the AHA. If your organization uses or intends to use any of the codes or other related content from the manual in this manner, please contact the AHA’s licensing manager, Tim Carlson, at 312.893.6816 or tcarlson@aha.org

* [AHA NUBC Patient Discharge Status Codes](http://terminology.hl7.org/5.5.0/CodeSystem-AHANUBCPatientDischargeStatus.html): [DAPLEncounter](StructureDefinition-dapl-deidentified-encounter.md)


* Most of the information on the CDC and ATSDR websites is not subject to copyright, is in the public domain, and may be freely used or reproduced without obtaining copyright permission. For information and exceptions regarding use of CDC material please see [[https://www.cdc.gov/other/agencymaterials.html](https://www.cdc.gov/other/agencymaterials.html)](https://www.cdc.gov/other/agencymaterials.html) 

* [Vaccine Administered Code Set (CVX)](http://terminology.hl7.org/5.5.0/CodeSystem-CVX.html): [Immunization/de-identified-example](Immunization-de-identified-example.md)


* Most of the information on the CDC and ATSDR websites is not subject to copyright, is in the public domain, and may be freely used or reproduced without obtaining copyright permission.For information and exceptions regarding use of CDC material please see [https://www.cdc.gov/other/agencymaterials.html](https://www.cdc.gov/other/agencymaterials.html).

* [CDC Race and Ethnicity](http://terminology.hl7.org/5.5.0/CodeSystem-CDCREC.html): [Bundle/dapl-deidentified-bundle](Bundle-dapl-deidentified-bundle.md), [Patient/de-identified-age89-example](Patient-de-identified-age89-example.md)... Show 4 more, [Patient/de-identified-example](Patient-de-identified-example.md), [Patient/de-identified-smallpop-example](Patient-de-identified-smallpop-example.md), [Patient/example](Patient-example.md) and [Patient/smallpop-example](Patient-smallpop-example.md)


* The ICD-9 is copyrighted by the World Health Organization (WHO), which owns and publishes the classification. WHO has authorized the development of an adaptation of ICD-9 for use in the United States for U.S. government purposes. As agreed, all modifications to the ICD-9 must conform to WHO conventions for the ICD. ICD-9-CM was developed following a thorough evaluation by a Technical Advisory Panel and extensive additional consultation with physician groups, clinical coders, and others to assure clinical accuracy and utility.

* [International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM)](http://tx.fhir.org/r4/ValueSet/icd-9-cm): [DAPLDiagnosis](StructureDefinition-dapl-diagnosis.md)


* The UCUM codes, UCUM table (regardless of format), and UCUM Specification are copyright 1999-2009, Regenstrief Institute, Inc. and the Unified Codes for Units of Measures (UCUM) Organization. All rights reserved. [https://ucum.org/trac/wiki/TermsOfUse](https://ucum.org/trac/wiki/TermsOfUse)

* [Unified Code for Units of Measure (UCUM)](http://terminology.hl7.org/5.5.0/CodeSystem-v3-ucum.html): [Bundle/dapl-deidentified-bundle](Bundle-dapl-deidentified-bundle.md), [Encounter/de-identified-example](Encounter-de-identified-example.md)... Show 7 more, [MedicationRequest/de-identified-example](MedicationRequest-de-identified-example.md), [MedicationStatement/de-identified-example](MedicationStatement-de-identified-example.md), [Observation/de-identified-income-with-quantity-example](Observation-de-identified-income-with-quantity-example.md), [Observation/de-identified-lab-observation-example](Observation-de-identified-lab-observation-example.md), [Patient/de-identified-age89-example](Patient-de-identified-age89-example.md), [Patient/de-identified-example](Patient-de-identified-example.md) and [Patient/de-identified-smallpop-example](Patient-de-identified-smallpop-example.md)


* This material contains content from [LOINC](http://loinc.org). LOINC is copyright © 1995-2020, Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee and is available at no cost under the [license](http://loinc.org/license). LOINC® is a registered United States trademark of Regenstrief Institute, Inc.

* [LOINC](http://terminology.hl7.org/5.5.0/CodeSystem-v3-loinc.html): [DAPLClinicalResultObservation](StructureDefinition-dapl-clinical-result-observation.md), [DAPLIncomeObservation](StructureDefinition-dapl-income-observation.md)... Show 8 more, [DAPLLabObservation](StructureDefinition-dapl-lab-observation.md), [DAPLProcedure](StructureDefinition-dapl-procedure.md), [DAPLServiceRequest](StructureDefinition-dapl-servicerequest.md), [Observation/de-identified-clinical-result-observation-example](Observation-de-identified-clinical-result-observation-example.md), [Observation/de-identified-income-example](Observation-de-identified-income-example.md), [Observation/de-identified-income-with-quantity-example](Observation-de-identified-income-with-quantity-example.md), [Observation/de-identified-lab-observation-example](Observation-de-identified-lab-observation-example.md) and [Observation/de-identified-low-income-example](Observation-de-identified-low-income-example.md)


* This material contains content that is copyright of SNOMED International. Implementers of these specifications must have the appropriate SNOMED CT Affiliate license - for more information contact [https://www.snomed.org/get-snomed](https://www.snomed.org/get-snomed) or [info@snomed.org](mailto:info@snomed.org).

* [SNOMED Clinical Terms&reg; (SNOMED CT&reg;)](http://hl7.org/fhir/R4/codesystem-snomedct.html): [AdverseEvent/de-identified-example](AdverseEvent-de-identified-example.md), [AllergyIntolerance/de-identified-example](AllergyIntolerance-de-identified-example.md)... Show 10 more, [Bundle/dapl-deidentified-bundle](Bundle-dapl-deidentified-bundle.md), [DAPLDeidentifiedAllergyIntolerance](StructureDefinition-dapl-deidentified-allergyintolerance.md), [DAPLDiagnosis](StructureDefinition-dapl-diagnosis.md), [DAPLEncounter](StructureDefinition-dapl-deidentified-encounter.md), [DAPLProcedure](StructureDefinition-dapl-procedure.md), [DAPLServiceRequest](StructureDefinition-dapl-servicerequest.md), [Observation/de-identified-lab-observation-example](Observation-de-identified-lab-observation-example.md), [Procedure/de-identified-example](Procedure-de-identified-example.md), [Procedure/de-identified-not-done-example](Procedure-de-identified-not-done-example.md) and [ServiceRequest/de-identified-example](ServiceRequest-de-identified-example.md)


* This material derives from the HL7 Terminology (THO). THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: [https://terminology.hl7.org/license.html](https://terminology.hl7.org/license.html)

* [AdverseEventCategory](http://terminology.hl7.org/7.1.0/CodeSystem-adverse-event-category.html): [AdverseEvent/de-identified-example](AdverseEvent-de-identified-example.md)
* [AllergyIntolerance Clinical Status Codes](http://terminology.hl7.org/7.1.0/CodeSystem-allergyintolerance-clinical.html): [AllergyIntolerance/de-identified-example](AllergyIntolerance-de-identified-example.md)
* [AllergyIntolerance Verification Status](http://terminology.hl7.org/7.1.0/CodeSystem-allergyintolerance-verification.html): [AllergyIntolerance/de-identified-example](AllergyIntolerance-de-identified-example.md)
* [Condition Category Codes](http://terminology.hl7.org/7.1.0/CodeSystem-condition-category.html): [Bundle/dapl-deidentified-bundle](Bundle-dapl-deidentified-bundle.md), [Condition/de-identified-example](Condition-de-identified-example.md), [Condition/example](Condition-example.md) and [Immunization/de-identified-example](Immunization-de-identified-example.md)
* [Condition Clinical Status Codes](http://terminology.hl7.org/7.1.0/CodeSystem-condition-clinical.html): [Bundle/dapl-deidentified-bundle](Bundle-dapl-deidentified-bundle.md), [Condition/de-identified-example](Condition-de-identified-example.md) and [Condition/example](Condition-example.md)
* [ConditionVerificationStatus](http://terminology.hl7.org/7.1.0/CodeSystem-condition-ver-status.html): [Bundle/dapl-deidentified-bundle](Bundle-dapl-deidentified-bundle.md), [Condition/de-identified-example](Condition-de-identified-example.md) and [Condition/example](Condition-example.md)
* [Observation Category Codes](http://terminology.hl7.org/7.1.0/CodeSystem-observation-category.html): [DAPLClinicalResultObservation](StructureDefinition-dapl-clinical-result-observation.md), [Observation/de-identified-clinical-result-observation-example](Observation-de-identified-clinical-result-observation-example.md) and [Observation/de-identified-lab-observation-example](Observation-de-identified-lab-observation-example.md)
* [Organization type](http://terminology.hl7.org/7.1.0/CodeSystem-organization-type.html): [Acme Health Plan](Organization-acme-payer.md), [Holy Healthcare](Organization-holy-healthcare.md) and [Organization/deidentified-organization-example](Organization-deidentified-organization-example.md)
* [contactRole2](http://terminology.hl7.org/7.1.0/CodeSystem-v2-0131.html): [DAPLDeidentifiedRelatedPerson](StructureDefinition-dapl-deidentified-relatedperson.md)
* [identifierType](http://terminology.hl7.org/7.1.0/CodeSystem-v2-0203.html): [Patient/example](Patient-example.md) and [Patient/smallpop-example](Patient-smallpop-example.md)
* [ActCode](http://terminology.hl7.org/7.1.0/CodeSystem-v3-ActCode.html): [Encounter/de-identified-example](Encounter-de-identified-example.md) and [Encounter/example](Encounter-example.md)
* [AdministrativeGender](http://terminology.hl7.org/7.1.0/CodeSystem-v3-AdministrativeGender.html): [DAPLSexCodes](ValueSet-dapl-sex-codes.md) and [DAPLSexExtension](StructureDefinition-dapl-sex-extension.md)
* [RoleCode](http://terminology.hl7.org/7.1.0/CodeSystem-v3-RoleCode.html): [DAPLDeidentifiedRelatedPerson](StructureDefinition-dapl-deidentified-relatedperson.md) and [RelatedPerson/de-identified-example](RelatedPerson-de-identified-example.md)


* Using RxNorm codes of type SAB=RXNORM as this specification describes does not require a UMLS license. Access to the full set of RxNorm definitions, and/or additional use of other RxNorm structures and information requires a UMLS license. The use of RxNorm in this specification is pursuant to HL7's status as a licensee of the NLM UMLS. HL7's license does not convey the right to use RxNorm to any users of this specification; implementers must acquire a license to use RxNorm in their own right.

* [RxNorm](http://terminology.hl7.org/5.5.0/CodeSystem-v3-rxNorm.html): [DAPLDeidentifiedAllergyIntolerance](StructureDefinition-dapl-deidentified-allergyintolerance.md), [MedicationRequest/de-identified-example](MedicationRequest-de-identified-example.md) and [MedicationStatement/de-identified-example](MedicationStatement-de-identified-example.md)


#### Expansion parameters

* Parameter: system-version
  * Value: SNOMED CT[US]

